Clinical Trials Directory

Trials / Completed

CompletedNCT02871011

Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot

A Blinded Placebo Controlled Clinical Trial To Evaluate Fungicidal Activity With The Topical Application Of Nitric Oxide Releasing Solution (Nors) In Subjects With Moderate To Severe Tinea Pedis (Athlete's Foot)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Nitric Solutions Inc. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the fungicidal efficacy of nitric oxide releasing solution footbath and it's effect on the clinical signs and symptoms associated with Tinea Pedis

Detailed description

Study Type: Interventional Study Design: Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Sequential Assignment Masking: Double Blind (Subject \& Assessor) Primary Purpose: Treatment

Conditions

Interventions

TypeNameDescription
DRUGNitric OxideDelivered as a footbath
DRUGWaterDelivered as a footbath

Timeline

Start date
2016-08-13
Primary completion
2016-11-14
Completion
2017-02-21
First posted
2016-08-18
Last updated
2019-09-20
Results posted
2019-09-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02871011. Inclusion in this directory is not an endorsement.

Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot (NCT02871011) · Clinical Trials Directory